Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gatorade + polyethylene glycol 3350 is a non-prescription bowel preparation regimen commonly used prior to colonoscopy or certain surgeries. It consists of mixing a specified amount of polyethylene glycol 3350 (PEG 3350), an osmotic laxative, with the sports drink Gatorade. PEG 3350 works by retaining water in the stool through osmotic action, leading to increased stool frequency and liquidity for effective colon cleansing. The addition of Gatorade provides electrolytes and flavoring, improving palatability and patient tolerance compared to traditional electrolyte-balanced PEG solutions. This combination is not FDA-approved for bowel prep but is widely used off-label due to its safety profile and patient satisfaction[1][2][5][6]. Studies show it is non-inferior in efficacy to standard prescription preparations when used as directed[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gatorade + polyethylene glycol 3350.